KAPIDIN 20 MG TBL FLM 100 II

What is the maximum co-payment for KAPIDIN?

If the insurance company contributes, the maximum co-payment is 287,03 Kč. The maximum pharmacy price is 399,07 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does KAPIDIN have a counted co-payment set?

Yes, the medicine has a counted co-payment of 287,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

112,04 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe KAPIDIN?

Prescription is not conditional on a medical specialization.

What is the composition of KAPIDIN?

Lerkanidipin-hydrochlorid (20 mg), lerkanidipin (18,8 mg), magnesium-stearát, povidon, neznámá látka s kódem 14679, monohydrát laktosy, neznámá látka s kódem 3755, neznámá látka s kódem 18564. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to KAPIDIN?

The medicine belongs to ATC group C08CA13 – LERKANIDIPIN. Medicines with the same active substance can be found here.

Who manufactures KAPIDIN?

Zentiva, k.s., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 22. 5. 2024. Production was terminated with effect from 22. 5. 2024. The manufacturer lists medicines with the following code as a potential substitute: